| |
| |
|
| Insider
Information: |
Shacham Sharon |
| Relationship: |
Chief Scientific Officer |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
958,131 |
|
|
Indirect Shares
|
713,757 |
|
|
| Direct
Value |
$1,087,479 |
|
|
|
Indirect Value
|
$810,114 |
|
|
| Total
Shares |
1,671,888 |
|
|
| Total
Value |
$1,897,593 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
12
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
12
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-12.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -553.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
Chief Scientific Officer |
2022-03-29 |
958,131 |
2022-03-29 |
713,757 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
146 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KPTI |
Karyopharm Therapeutics I... |
CSO & Pres. Res. & Dev. |
• – – |
2013-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
132,575 |
753,346 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
I/I |
57,200 |
718,826 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
57,200 |
920,152 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Scientific Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
I/I |
21,000 |
719,983 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Scientific Officer |
• – – |
2022-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
958,131 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2014-06-17 |
4 |
AS |
$40.36 |
$403,635 |
D/D |
(10,000) |
908,963 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2014-06-18 |
4 |
AS |
$43.15 |
$431,523 |
I/I |
(10,000) |
687,596 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2017-12-07 |
4 |
AS |
$10.39 |
$103,903 |
D/D |
(10,000) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2017-12-18 |
4 |
AS |
$9.16 |
$91,553 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-01-08 |
4 |
AS |
$10.08 |
$100,769 |
D/D |
(10,000) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-01-18 |
4 |
AS |
$10.09 |
$100,882 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-02-07 |
4 |
AS |
$12.50 |
$125,048 |
D/D |
(10,000) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-02-20 |
4 |
AS |
$14.79 |
$147,872 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-03-07 |
4 |
AS |
$16.15 |
$161,463 |
D/D |
(10,000) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-03-19 |
4 |
AS |
$15.29 |
$152,895 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-04-09 |
4 |
AS |
$12.48 |
$124,829 |
D/D |
(10,000) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-04-18 |
4 |
AS |
$14.79 |
$147,878 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-05-07 |
4 |
AS |
$16.77 |
$167,747 |
D/D |
(10,000) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-05-18 |
4 |
AS |
$19.39 |
$193,870 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-06-07 |
4 |
AS |
$17.30 |
$172,991 |
D/D |
(10,000) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-06-18 |
4 |
AS |
$18.66 |
$186,558 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-07-09 |
4 |
AS |
$18.72 |
$233,990 |
D/D |
(12,500) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-07-18 |
4 |
AS |
$18.27 |
$182,686 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-08-07 |
4 |
AS |
$18.04 |
$225,556 |
D/D |
(12,500) |
713,510 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
President & CSO |
• – – |
2018-08-20 |
4 |
AS |
$17.46 |
$174,568 |
I/I |
(10,000) |
512,143 |
0 |
- |
|
146 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
